Imidazo [4, 5-C] quinoline derivatives as bromodomain inhibitors

US8557984B2 · kind B2 · utility

Assignee

• GlaxoSmithKline LLC · US

Inventors

• Anne Marie Jeanne Bouillot · Les Ulis, FR
• Frederic G. Donche · Les Ulis, FR
• Francoise Gellibert · Cachan, FR
• Yann Lamotte · Les Ulis, FR
• Olivier Mirguet · Les Ulis, FR

Key dates

• Filing date: Nov 3, 2010
• Grant date: Oct 15, 2013
• Expiry date: Nov 3, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel compounds of formula (I)and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy.